Not Just Another Reporting Guideline? Here's Why READUS-PV is a Major Step Forward

Affiliations

Editorial

Yoon K Loke. Drug Saf. 2024 Jun.

. 2024 Jun;47(6):571-573.

doi: 10.1007/s40264-024-01441-5. Epub 2024 May 8.

¹ Norwich Medical School, University of East Anglia, Norwich, NR4 7TJ, UK. y.loke@uea.ac.uk.

No abstract available

Comment on

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.
Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, Brueckner A, Candore G, Carnovale C, Crisafulli S, Cutroneo PM, Dolladille C, Drici MD, Faillie JL, Goldman A, Hauben M, Herdeiro MT, Mahaux O, Manlik K, Montastruc F, Noguchi Y, Norén GN, Noseda R, Onakpoya IJ, Pariente A, Poluzzi E, Salem M, Sartori D, Trinh NTH, Tuccori M, van Hunsel F, van Puijenbroek E, Raschi E, Khouri C. Fusaroli M, et al. Drug Saf. 2024 Jun;47(6):575-584. doi: 10.1007/s40264-024-01421-9. Epub 2024 May 7. Drug Saf. 2024. PMID: 38713346 Free PMC article.
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.
Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, Brueckner A, Candore G, Carnovale C, Crisafulli S, Cutroneo PM, Dolladille C, Drici MD, Faillie JL, Goldman A, Hauben M, Herdeiro MT, Mahaux O, Manlik K, Montastruc F, Noguchi Y, Norén GN, Noseda R, Onakpoya IJ, Pariente A, Poluzzi E, Salem M, Sartori D, Trinh NTH, Tuccori M, van Hunsel F, van Puijenbroek E, Raschi E, Khouri C. Fusaroli M, et al. Drug Saf. 2024 Jun;47(6):585-599. doi: 10.1007/s40264-024-01423-7. Epub 2024 May 7. Drug Saf. 2024. PMID: 38713347 Free PMC article.

1. Fusaroli M, Salvo F, Begaud B, Alshammari T, Bate A, Battini V, et al. The REporting of A Disproportionality analysis for drUg Safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): development and statement. Drug Saf. 2024. https://doi.org/10.1007/s40264-024-01421-9 . - DOI - PubMed - PMC
1. Fusaroli M, Salvo F, Begaud B, Alshammari T, Bate A, Battini V, et al. The REporting of A Disproportionality analysis for drUg Safety signal detection using individual case safety reports in PharmacoVigilance (READUS-PV): explanation and elaboration. Drug Saf. 2024. https://doi.org/10.1007/s40264-024-01423-7 . - DOI - PubMed - PMC
1. EQUATOR. EQUATOR Network. https://www.equator-network.org/ . Accessed 14 Apr 2024.
1. Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483–6. - DOI - PubMed
1. de Boer A. When to publish measures of disproportionality derived from spontaneous reporting databases? Br J Clin Pharmacol. 2011;72(6):909–11. - DOI - PubMed - PMC